260 HOW GOOD IS ALLOGRAFT CARTILAGE?  by Kirk, S. et al.
S118 Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256
(catabolic stimulation), prednisolone + OSM + TNF-α, or IGF-I [100 nM]
(anabolic stimulation). The conditioned medium from days 7 and 14 were
measured and examined for biochemical markers of bone and cartilage
degradation/formation.
Results: The cartilage degradation increased ∼25-fold (day 7) and ∼20-fold
(day 14) when stimulated with the cytokines, OSM + TNF-α, compared
with the non-stimulated vehicles (P<0.001). Additional stimulation with
prednisolone inhibited the catabolic effects by OSM + TNF-α at both days
(P<0.01). The bone resorption also increased ∼5.5-fold (day 7) when
stimulated with OSM + TNF-α, compared with the vehicle (P<0.001). Again,
additional stimulation with prednisolone inhibited the catabolic effect on
bone resorption by OSM + TNF-α (P<0.05). No resorption was detected for
any treatments at day 14.
Prednisolone stimulation did not affect the cartilage formation. However,
IGF-I stimulation increased cartilage formation by ∼2.7-fold (day 14) com-
pared with the vehicle (P<0.001). OSM + TNF-α stimulation inhibited all
cartilage formation (P<0.001).
The bone formation was not affected by prednisolone stimulation at day 7.
However, at day 14, prednisolone decreased the bone formation by ∼8.9
fold compared with vehicle (P<0.001). IGF-I stimulation increased the bone
formation ∼2.5-fold (day 7) and ∼2.6-fold (day 14), compared with the
vehicles (P<0.001). OSM + TNF-α stimulation decreased bone formation
by ∼3.5-fold (day 7) compared with vehicle, and completely inhibited the
formation at day 14 (P<0.001).
Conclusions: Prednisolone inhibits cytokine-induced cartilage degradation
and bone resorption, indicating an anti-catabolic effect on chondrocytes
and osteoclasts. Cartilage formation is not affected by prednisolone, which
supports the literature suggesting that glucocorticoids protect cartilage.
However, bone formation decreased when stimulated with prednisolone,
suggesting that prednisolone catabolically affects the osteoblasts. This
overall indicates that prednisolone decreases bone turnover and protects
cartilage against degradation.
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Purpose: The purpose of this study was to evaluate the effect of pro-
inﬂammatory cytokines on the metabolism and survival of chondrocytes
obtained from osteochondral allografts (OA) as compared to fresh chondro-
cytes obtained from human organ donors.
Methods: Nine OA specimens (hemicondyle), previously refrigerated for
14-28 days, were collected at the time of surgery and six fresh hemi-
condyles were obtained from normal donors within 24 hours of death
through the Gift of Hope Organ and Tissue Donor Network. 4mm tissue
explants from OA and fresh cartilage were cultured in media containing
10% fetal bovine serum and divided into the following treatment groups:
1) culture control (serum only), 2) IL-1β (0.1 ng/ml), 3) IL-6 (3ng/ml), 4)
IL-1β (0.1 ng/ml) + IL-6 (3ng/ml), 5) IL-1β (10 ng/ml), 6) IL-1β (10 ng/ml)
+ IL-6 (3ng/ml). IL-6 soluble receptor (5ng/ml) was added to all cultures
containing IL-6. Doses of cytokines were determined based on synovial
ﬂuid levels in patients undergoing allograft transplantation. Treatment was
administered every other day. Tissue and media were collected on days 0,
2, 7, and 14. Cell viability (live/dead assay), apoptosis (Tunel assay), his-
tological appearance with Safranin O staining, proteoglycan (PG) synthesis
and content (normalized to wet weight) were used to analyze cartilage
survival and metabolism.
Results: At day zero, the viability of OA chondrocytes was 24% lower and
they contained 29% more apoptotic cells than fresh chondrocytes (p<0.05).
Treatment with cytokines did not further induce cell death or apoptosis
in OA cartilage. However, in fresh cartilage, treatment with high dose IL-1
(10ng/ml) alone or in combination with IL-6 showed a signiﬁcant decrease
in chondrocyte viability by day 14 (p<0.05 and p=0.05 correspondingly)
as well as a signiﬁcant increase in the number of apoptotic cells (p=0.05
and p<0.05) when compared to day 0 control. Fresh chondrocytes showed
2.5 times greater PG synthesis (p<0.05) and only half as much release of
PGs into the media (p<0.01) when compared to OA chondrocytes at day 0.
However, fresh chondrocytes were more sensitive to cytokine treatments:
by day 14 high dose IL-1 alone or combined with IL-6 inhibited PG
synthesis by more than 8-fold (p<0.02) vs 4-fold in OA cells (p<0.02) and
induced higher PG release, which resulted in higher Mankin score for fresh
cartilage (1.3 vs 3.0, p<0.04).
Conclusions: The viability and metabolism of OA cartilage is signiﬁcantly
lower than fresh cartilage; however, OA cartilage is more resistant to
cytokine treatment. The reduced metabolism and sensitivity of OA cartilage
might explain allograft survival in an acute inﬂammatory environment (at
least short-term) suggesting that OA cartilage may act more like a scaffold
rather than an active tissue. Further long-term studies are warranted in
order to understand the performance of OA cartilage.
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Purpose: It is increasingly recognised that the overproduction of mediators
such as Nitric Oxide (NO) in Osteoarthritic cartilage contributes to the
disease pathology partly by inducing chondrocyte apoptosis via the mi-
tochondrial pathway. Therefore, agents which protect against NO-induced
mitochondrial injury may have therapeutic potential in Osteoarthritis (OA).
We have previously shown that the human chondrocyte cell line C-20/A4
produces members of the Urocortin (Ucn) family of peptides in response
to pro-apoptotic insults and that exogenous administration of all of these
peptides protects chondrocytes from NO induced apoptosis with Ucn I
being the most potent. The purpose of this study was to elucidate poten-
tial mechanisms of action and signalling pathways through which these
peptides may exert their effects.
Methods: C-20/A4 cells were maintained in monolayer culture in a Dul-
becco’s MEM (DMEM) - based medium containing 10% foetal calf serum
(FCS) at 37 °C and 5% CO2. Prior to treatment, cells were transferred to
T25 tissue culture ﬂasks, allowed to reach approx. 80% conﬂuency and then
serum-starved for 24 hours in DMEM based medium containing 1% FCS and
then treated with 1mM SNAP (NO donor) for 6 hours. CRH receptor and
KATP channel subunit expression were analysed by RT-PCR. p42/44 MAPK
activation was studied by western blotting with antibodies speciﬁc for total
and phosphorylated p42/44. Apoptotic cell death was assessed by Annexin
V/PI binding and TUNEL assay with necrosis assessed by LDH release
Results: The addition of Ucn1 to SNAP treated C-20/A4 cells provides
protection against apoptosis which is abrogated by the addition of the
CRFR antagonist αhCRH suggesting the presence of CRH receptors on these
cells the expression of which was conﬁrmed by RT-PCR demonstrating
the expression of both corticotropin releasing factor receptors, CRFR1 and
CRFR2 mRNA, speciﬁcally the CRFR1α and CRFR2β splice variants. Further
RT-PCR studies demonstrate the expression of both the Kir and SUR
subunits of the mitochondrial ATP sensitive inwardly rectifying potassium
channel with western blotting studies indicating a Ucn mediated increase
in p42/44 MAPK activation, representing possible mechanisms for Ucn
mediated chondroprotection.
Conclusions: Studies with αhCRH and RT-PCR analysis for the expression of
CRFR receptors indicate the presence of two active forms of the CRF recep-
tors, CRFR1α and CRFR2β on C-20/A4 chondrocytes. The presence of these
receptors provides a putative cell surface binding site for Ucn family mem-
